Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-EN | Version v5-EN | |
---|---|---|
Language | English | English |
Date Updated | 2021-08-02 | 2021-07-30 |
Drug Identification Number | 02327848 | 02327848 |
Brand name | NEUROLITE | NEUROLITE |
Common or Proper name | Kit for the Preparation of Technetium Tc99m Bicisate for Injection | Kit for the Preparation of Technetium Tc99m Bicisate for Injection |
Company Name | LANTHEUS MI CANADA INC | LANTHEUS MI CANADA INC |
Ingredients | BICISATE DIHYDROCHLORIDE | BICISATE DIHYDROCHLORIDE |
Strength(s) | 0.9MG | 0.9MG |
Dosage form(s) | POWDER FOR SOLUTION KIT | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | Kits of 2 and kits of 5 vials | Kits of 2 and kits of 5 vials |
ATC code | V09A | V09A |
ATC description | ||
Reason for shortage | Shortage of an inactive ingredient or component. | Shortage of an inactive ingredient or component. |
Anticipated start date | 2021-08-01 | 2021-08-01 |
Actual start date | ||
Estimated end date | 2021-08-31 | 2021-08-31 |
Actual end date | ||
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | ||
Health Canada comments |